血液生物标志物：使阿尔茨海默病诊断民主化。

Blood Biomarkers: Democratizing Alzheimer's Diagnostics.

机构信息

Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, the Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden; Department of Neurodegenerative Disease, UCL Institute of Neurology, Queen Square, London, UK; UK Dementia Research Institute at UCL, London, UK.

出版信息

Neuron. 2020 Jun 17;106(6):881-883. doi: 10.1016/j.neuron.2020.06.004.

DOI:10.1016/j.neuron.2020.06.004

PMID:32553204

Abstract

Currently available biomarkers for Alzheimer's disease are of limited availability due to high costs and perceived invasiveness. New studies reveal that Alzheimer's pathologies now can be reliably quantified in vivo using regular blood tests.

摘要

目前，由于成本高和侵入性强，阿尔茨海默病的生物标志物的应用受到限制。新的研究表明，现在可以使用常规血液检测在体内可靠地定量阿尔茨海默病的病理。